37 results
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... for Preventing ... Preventing First ... HumanPapillomavirus #IDSA ... #Prevention #Treatment
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... for Preventing ... Preventing 1st ... to 5 mg/kg/day IV ... Penicilliosis #IDSA
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... for Preventing ... Preventing Bacterial ... Enteric #Bacterial #IDSA ... #Prevention #Treatment
IDSA Algorithm for the Initial Management of Fever and Neutropenia

LOW RISK
 • Antidpated neutropenia < 7
IDSA Algorithm for ... and clinically stable ... neutropenic #fever #IDSA ... #Algorithm #Management
"Recommended laboratory HIV testing algorithm for serum or plasma specimens. Based on: Centers for Disease Control
Recommended laboratory HIV ... testing algorithm ... Disease Control and Prevention ... the Diagnosis of HIV ... CDC #Diagnosis #Algorithm
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
IDSA Recommendations ... for Preventing ... Trypanosomiasis) in HIV-AIDS ... Preventing Clinical ... Trypanosomiasis #IDSA
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... mucoadhesive buccal tablet ... chew, or crush tablet ... candida #mucosal #IDSA ... #Prevention #Treatment
Acute ED Migraine Therapy and Preventative Therapy Algorithm:
Acute migraine
 • IV NS IL bolus then infusion
Preventative Therapy Algorithm ... Acute migraine • IV ... • Ketorolac IV ... Migraine #management #algorithm ... #treatment #prevention
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
IDSA Recommendations ... Leishmaniasis in HIV-AIDS ... amphotericin B 2–4 mg/kg IV ... amphotericin B 2–4 mg/kg IV ... Leishmaniasis #Prevention
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 • Fluid
IDSA Recommendations ... 800 mg) PO (or IV ... 800 mg) PO (or IV ... IsosporaBelli #IDSA ... #Prevention #Treatment